Bank of America’s Envoy Medical COCH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-2
Closed -$1 5957
2025
Q4
$1 Sell
2
-5
-71% -$4 ﹤0.01% 7268
2025
Q3
$5 Sell
7
-69
-91% -$94 ﹤0.01% 8243
2025
Q2
$107 Buy
76
+10
+15% +$15 ﹤0.01% 7959
2025
Q1
$86 Buy
66
+6
+10% +$9 ﹤0.01% 7860
2024
Q4
$86 Sell
60
-14
-19% -$32 ﹤0.01% 7769
2024
Q3
$240 Buy
74
+17
+30% +$46 ﹤0.01% 7526
2024
Q2
$135 Buy
+57
New +$212 ﹤0.01% 7645
2023
Q1
Sell
-1,000
Closed -$10K 7860
2022
Q4
$10K Hold
1,000
﹤0.01% 6921
2022
Q3
$10K Sell
1,000
-144,239
-99% -$1.42M ﹤0.01% 7228
2022
Q2
$1.42M Sell
145,239
-18
-0% -$176 ﹤0.01% 4599
2022
Q1
$1.42M Hold
145,257
﹤0.01% 4905
2021
Q4
$1.42M Sell
145,257
-81,811
-36% -$798K ﹤0.01% 4914
2021
Q3
$2.21M Hold
227,068
﹤0.01% 4360
2021
Q2
$2.21M Buy
+227,068
New +$2.21M ﹤0.01% 4235

Other funds holding COCH

Bank of America's COCH Position: Q1 2026 in Review

Bank of America sold out of Envoy Medical (COCH) in Q1 2026, closing a stake of 2 shares — an estimated $1 sold.

Bank of America first reported a position in COCH in Q2 2021 and held it in 14 quarters. The position peaked at $2.21M in Q2 2021. 33 funds tracked by Wall St. Rank hold COCH as of Q1 2026.

  • Bank of America reported no remaining Envoy Medical position as of Q1 2026 after selling out during the quarter.
  • Bank of America sold 2 Envoy Medical shares in Q1 2026, an estimated $1.
  • Bank of America first reported a position in Envoy Medical in Q2 2021 and held it in 14 quarters.
  • Bank of America's Envoy Medical position peaked at $2.21M in Q2 2021.
  • 33 funds tracked by Wall St. Rank held Envoy Medical as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.